Table 1.
Demographic and clinical characteristics of subjects involved in this study
| Healthy controls (n = 34) | Active UC (n = 34) | Stable remission UC (n = 34) | P | |
|---|---|---|---|---|
| Male sex (n, %) | 17 (50·0) | 18 (52·9) | 17 (50·0) | 0·3651 |
| Age, years (median, IQR) | 41 (21–53) | 40 (21–55) | 38 (20–54) | 0·0895 |
| WBC,109/l (median, IQR) | 6·43 (5·03–7·52) | 6·54 (4·83–8·68) | 6·49 (5·17–8·16) | 0·2938 |
| Lymphocyte, 109/l (median, IQR) | 1·87 (1·59–2·41) | 1·92 (1·47–2·33) | 1·90 (1·45–2·19) | 0·0913 |
| IgG, mg/l (median, IQR) | 11·9 (10·8–12·9) | 16·3 (12·6–18·8) | 12·8 (10·7–14·7) | 0·0060 |
| Hemoglobin,g/l (median, IQR) | 145 (129–159) | 112 (100–135) | 137 (124–155) | < 0·0001 |
| Albumin, g/l (median, IQR) | 45·8 (41·9–48·3) | 36·8 (32·5–42·1) | 43·4 (38·8–45·1) | < 0·0001 |
| CRP, mg/l (median, IQR) | – | 23·9 (14·2–41·6) | 2·56 (0·81–6·41) | < 0·0001 |
| Mayo score (median, IQR) | – | 7 (5–9) | 2 (1–2) | < 0·0001 |
IQR = 25th–75th; UC = ulcerative colitis; HCs, healthy controls; WBC = white blood cells; CRP = C‐reactive protein.